This episode tackles the unique challenges encountered when formulating biologics and injectables, particularly regarding sterility and stability. It compares and contrasts the formulation challenges of small molecule drugs versus biologics, highlighting the complexities associated with larger, more fragile biomolecules. The discussion explores the stringent manufacturing processes required for injectables to ensure sterility and prevent contamination. Real-world examples from OPR&D and other sources illustrate these challenges and the innovative solutions employed to overcome them.

Beyond simply dissolving a drug in a solution, formulating injectables requires meticulous attention to detail to ensure patient safety. The episode emphasizes the importance of maintaining stability in biologics, which are prone to degradation and aggregati ...